Article
mHTT Seeding Activity: A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease.
Molecular cell - 6 Sept 2018
Ast Anne, Buntru Alexander, Schindler Franziska, Hasenkopf Regine, Schulz Aline, Brusendorf Lydia, Klockmeier Konrad, Grelle Gerlinde, McMahon Benjamin, Niederlechner Hannah, Jansen Isabelle, Diez Lisa, Edel Juliane, Boeddrich Annett, Franklin Sophie A, Baldo Barbara, Schnoegl Sigrid, Kunz Severine, Purfürst Bettina, Gaertner Annette, Kampinga Harm H, Morton A Jennifer, Petersén Åsa, Kirstein Janine, Bates Gillian P, Wanker Erich E
Abstract excerpt
Self-propagating, amyloidogenic mutant huntingtin (mHTT) aggregates may drive progression of Huntington's disease (HD). Here, we report the development of a FRET-based mHTT aggregate seeding (FRASE) assay that enables the quantification of mHTT seeding activity (HSA) in complex biosamples from HD patients and disease models. Application of the FRASE assay revealed HSA in brain homogenates of presymptomatic HD...
Topics
- Animals
- Animals, Genetically Modified
- Biomarkers
- Brain
- Caenorhabditis elegans
- Disease Models, Animal
- Disease Progression
- Drosophila
